Last updated on February 2018

PMS for Idarucizumab in Japan


Brief description of study

To evaluate safety and effectiveness of Prizbind for Intravenous Solution 2.5 g under Japanese clinical condition

Clinical Study Identifier: NCT02946931

Contact Investigators or Research Sites near you

Start Over